X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (570) 570
Publication (16) 16
Newsletter (15) 15
Book Review (8) 8
Book Chapter (4) 4
Conference Proceeding (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (369) 369
pyrazinamide (308) 308
tuberculosis (290) 290
male (225) 225
female (221) 221
adult (201) 201
index medicus (196) 196
antitubercular agents - adverse effects (170) 170
antitubercular agents - therapeutic use (166) 166
middle aged (151) 151
rifampin (146) 146
tuberculosis, pulmonary - drug therapy (139) 139
drug therapy, combination (136) 136
pyrazinamide - therapeutic use (125) 125
isoniazid (119) 119
pyrazinamide - adverse effects (107) 107
isoniazid - therapeutic use (104) 104
rifampin - therapeutic use (103) 103
tuberculosis - drug therapy (103) 103
antitubercular agents - administration & dosage (97) 97
drug therapy (93) 93
antitubercular agents (91) 91
rifampin - administration & dosage (88) 88
rifampin - adverse effects (88) 88
aged (87) 87
adolescent (86) 86
pyrazinamide - administration & dosage (86) 86
isoniazid - adverse effects (85) 85
pulmonary tuberculosis (82) 82
drugs (81) 81
isoniazid - administration & dosage (77) 77
rifampicin (77) 77
infectious diseases (76) 76
risk factors (75) 75
treatment outcome (74) 74
pharmacology & pharmacy (73) 73
ethambutol (71) 71
hepatotoxicity (70) 70
respiratory system (66) 66
ethambutol - therapeutic use (64) 64
chemotherapy (57) 57
mycobacterium-tuberculosis (57) 57
drug administration schedule (56) 56
complications and side effects (53) 53
dosage and administration (47) 47
child (46) 46
hepatitis (46) 46
antituberculosis drugs (44) 44
chemical and drug induced liver injury - etiology (42) 42
pharmacokinetics (41) 41
pyrazinamide, adverse reactions (41) 41
risk-factors (41) 41
therapy (40) 40
care and treatment (39) 39
liver (39) 39
medicine (39) 39
medicine & public health (39) 39
time factors (39) 39
infection (38) 38
patients (38) 38
ethambutol - adverse effects (37) 37
health aspects (37) 37
medicine, general & internal (37) 37
young adult (37) 37
analysis (36) 36
animals (36) 36
immunology (36) 36
prospective studies (36) 36
retrospective studies (36) 36
ethambutol - administration & dosage (35) 35
drug resistance (34) 34
hiv (33) 33
mycobacterium tuberculosis (33) 33
research (33) 33
diagnosis (31) 31
mycobacterium tuberculosis - drug effects (31) 31
pyrazinamide, adverse reactions - serious (31) 31
aged, 80 and over (30) 30
tuberculosis, multidrug-resistant - drug therapy (29) 29
liver diseases (28) 28
medical research (28) 28
patient outcomes (28) 28
pharmacology/toxicology (28) 28
research article (28) 28
rifampicin, adverse reactions (28) 28
sputum - microbiology (28) 28
child, preschool (27) 27
clinical trials as topic (27) 27
drug combinations (27) 27
follow-up studies (27) 27
rifampicin, adverse reactions - serious (27) 27
infections (26) 26
streptomycin - therapeutic use (26) 26
antitubercular agents - pharmacokinetics (25) 25
antitubercular agents - pharmacology (25) 25
isoniazid, adverse reactions - serious (25) 25
moxifloxacin (25) 25
streptomycin - administration & dosage (25) 25
susceptibility (25) 25
toxicity (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (553) 553
French (9) 9
Japanese (5) 5
German (4) 4
Portuguese (4) 4
Russian (4) 4
Chinese (2) 2
Polish (2) 2
Spanish (2) 2
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e65037
Journal Article
EXPERT OPINION ON DRUG SAFETY, ISSN 1474-0338, 03/2006, Volume 5, Issue 2, pp. 231 - 249
Journal Article
JORNAL BRASILEIRO DE PNEUMOLOGIA, ISSN 1806-3713, 01/2015, Volume 41, Issue 1, pp. 77 - 89
This review sought to identify the available scientific evidence on risk factors associated with adverse reactions to antituberculosis drugs. We performed a... 
RIFAMPIN | Review | REGIMENS | CHEMOTHERAPY | INDUCED HEPATITIS | Tuberculosis | Drug-related side effects and adverse reactions | HIV | RESPIRATORY SYSTEM | PULMONARY TUBERCULOSIS | Antitubercular agents | PYRAZINAMIDE | HEPATOTOXICITY | HEALTH
Journal Article
Journal Article
Journal Article
CNS Drugs, ISSN 1172-7047, 8/2010, Volume 24, Issue 8, pp. 655 - 667
Nervous system toxicity with current antituberculosis pharmacotherapy is relatively uncommon, although the frequency of the usage of antituberculosis therapy... 
Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | Pyrazinamide, adverse reactions | Aminoglycosides, adverse reactions | Ethambutol, adverse reactions | Antituberculars, adverse reactions | Adverse-drug-reactions | Isoniazid, adverse reactions | Cycloserine, adverse reactions | Metronidazole, adverse reactions | Tuberculosis | Aminosalicylic-acid, adverse reactions | Ethionamide, adverse reactions | Thioacetazone, adverse reactions | Linezolid, adverse reactions | Meropenem, adverse reactions | Rifampicin, adverse reactions | Fluoroquinolones, adverse reactions | Capreomycin, adverse reactions | MYCOBACTERIUM-TUBERCULOSIS | OCULAR ETHAMBUTOL TOXICITY | DRUG-INTERACTIONS | PSYCHIATRY | D-CYCLOSERINE | SCHIZOPHRENIA | AMINOGLYCOSIDE ANTIBIOTICS | CLINICAL NEUROLOGY | SEIZURE | RESISTANCE | PERIPHERAL NEUROPATHY | PHARMACOLOGY & PHARMACY | METRONIDAZOLE | Antitubercular Agents - adverse effects | Humans | Antitubercular Agents - pharmacology | Male | Animals | Mycobacterium tuberculosis | Tuberculosis - drug therapy | Central Nervous System - drug effects | Female | Nervous System Diseases - chemically induced | Antitubercular Agents - poisoning | Antitubercular Agents - therapeutic use | Peripheral Nervous System - drug effects | Complications and side effects | Antitubercular agents | Nervous system diseases | Dosage and administration | Research | Risk factors | Index Medicus
Journal Article
Molecular Diagnosis and Therapy, ISSN 1177-1062, 2012, Volume 16, Issue 4, pp. 241 - 250
  Background: Adverse drug reactions (ADRs) associated with anti-tuberculosis (anti-TB) drug regimens have considerable impact on anti-TB treatment,... 
Pharmacogenetics | Rifampicin | Tuberculosis | Cytochrome-P450 | Adverse-drug-reactions | Genetic-polymorphism | Pyrazinamide | Isoniazid
Journal Article
International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 12/2009, Volume 13, Issue 12, pp. 1560 - 1562
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 10/2007, Volume 16, Issue 10, pp. 1104 - 1110
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 08/2011, Volume 69, Issue 8, p. 1389
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 02/2017, Volume 176, Issue 2, pp. 378 - 386
Journal Article
International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 08/2007, Volume 11, Issue 8, pp. 868 - 875
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 12/2018, Volume 43, Issue 6, pp. 790 - 798
Journal Article
Journal Article